Does IRBESARTAN Cause Interstitial lung disease? 72 Reports in FDA Database
Lower Your Cholesterol — The Natural Way
The Oxidized Cholesterol Strategy: a science-backed plan for heart health.
According to the FDA Adverse Event Reporting System (FAERS), 72 reports of Interstitial lung disease have been filed in association with IRBESARTAN (Irbesartan). This represents 0.7% of all adverse event reports for IRBESARTAN.
72
Reports of Interstitial lung disease with IRBESARTAN
0.7%
of all IRBESARTAN reports
45
Deaths
36
Hospitalizations
How Dangerous Is Interstitial lung disease From IRBESARTAN?
Of the 72 reports, 45 (62.5%) resulted in death, 36 (50.0%) required hospitalization, and 5 (6.9%) were considered life-threatening.
Is Interstitial lung disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for IRBESARTAN. However, 72 reports have been filed with the FAERS database.
What Other Side Effects Does IRBESARTAN Cause?
Acute kidney injury (1,361)
Fall (795)
Hypotension (686)
Nausea (533)
Drug ineffective (532)
Malaise (488)
Hyponatraemia (485)
Fatigue (483)
Blood pressure increased (477)
Hyperkalaemia (454)
What Other Drugs Cause Interstitial lung disease?
METHOTREXATE (3,049)
RITUXIMAB (2,458)
PEMBROLIZUMAB (2,113)
PREDNISONE (1,850)
CYCLOPHOSPHAMIDE (1,725)
NIVOLUMAB (1,538)
AMIODARONE (1,421)
DOXORUBICIN (1,352)
ETANERCEPT (1,267)
ADALIMUMAB (1,250)
Which IRBESARTAN Alternatives Have Lower Interstitial lung disease Risk?
IRBESARTAN vs IRINOTECAN
IRBESARTAN vs IRON
IRBESARTAN vs IRON DEXTRAN
IRBESARTAN vs IRON ISOMALTOSIDE 1000
IRBESARTAN vs IRON POLYMALTOSE